Recognizing Shockwave’s commitment to drive value through clinical excellence and commitment to lower costs, Shockwave was announced a winner of the Supplier Horizon Award from Premier Inc., a leading healthcare improvement and technology company that unites an alliance of more than 4,400 U.S. hospitals and health systems and approximately 225,000 other providers. We're thrilled to be honored by Premier Inc. as a Supplier Horizon winner at the Breakthroughs Conference 2022 as it represents the support provided to Premier members of “exceptional customer service and engagement.”
Shockwave received this award for being a preferred supplier in the healthcare industry and demonstrating “unwavering commitment to delivering top value products and services designed to continually improve patient care.” This award, “recognizes suppliers - with less than three years of Premier tenure in a specific service line - that consistently support our members at the highest levels of partnership, customer service, value creation, clinical excellence, and commitment to lower costs.” Shockwave supports Premier members by offering valuable products and services that help to lower supply chain costs and improve operating efficiencies,” said David A. Hargraves, Senior Vice President, Supply Chain, Premier, “We’re honored to recognize them as a Horizon Award recipient.”
The full list of Premier’s 2022 Supplier Horizon Award winners can be found here.
Read More
Topics:
IVL Technology,
SWAV News
At Shockwave, we are committed to doing everything we can to narrow the PCI gender inequality gap starting with clinical evidence presented at SCAI 2022 where Coronary IVL demonstrated sustained long term clinical outcomes and excellent safety in both women and men suggesting first line use of Coronary IVL for plaque modification in female patients with calcified lesions.
Read More
Topics:
Coronary IVL,
IVL Technology,
Coronary Clinical Data,
SWAV News,
Shockwave C2,
Coronary Conferences,
Female vs. Male Outcomes
With calcium being as hot of a topic as ever in the interventional community, now is the time to invest in research to better understand its impact across patient populations and trends in modification techniques. Shockwave, in partnership with SCAI, is sponsoring a $50,000 grant for research that improves current understanding of calcified lesions. This one-time grant is eligible for SCAI members within 10 years of completing an Interventional Cardiology fellowship. Research must last 1-year and focus within one of the two following areas:
- Disparities in the treatment of calcified lesions (e.g. gender, race/gender, age)
- Recent treatment and outcome trends in coronary calcium modification (per NCDR)
Applicants are encouraged to access the application instructions at this link. Submissions open May 21, 2022 and close August 21, 2022. Awardees will be notified in September 2022.
We hope this grant improves knowledge & understanding of calcified lesions and further informs us of gender, race and age disparities in coronary calcium modification outcomes.
SCAI Early Career Research Grants presented by Dr Sunil Rao at SCAI 2022
Read More
Topics:
Coronary IVL,
IVL Technology,
SWAV News,
Female vs. Male Outcomes
In episode #9 of the ChalkTalk podcast, we speak with Alexandra Lansky, MD, FACC, FAHA, FSCAI, FESC, Professor of Medicine in Cardiology, and Director of Yale Cardiovascular Clinical Research Program at Yale University School of Medicine in New Haven, Connecticut, about her recent gender analyses at TCT21 and SCAI22, in which she presented the respective 30-day and 1-year outcomes broken out by women vs men that were enrolled in the Disrupt CAD clinical program.
Dr. Lansky shares the genesis of the analysis - previous research showing that female atherectomy patients have an increased risk for angiographic complications than their male counterparts,[i] and sheds light on what makes coronary IVL unique from a safety perspective. She concludes by discussing the recent publication of SCAI’s “Expert Consensus Statement on Sex-Specific Consideration in Myocardial Revascularization” in JSCAI, which referenced the role of IVL in female patients. The SCAI guidelines concluded, “while additional evidence is needed, these results taken in the context of outcomes with atherectomy devices suggest that IVL may emerge as a first-line therapy for plaque modification of calcified lesions in women specifically.”
We hope you enjoy the episode and for more information on coronary IVL in women, please visit TimeForAnIntervention.com.
Read More
Topics:
Coronary IVL,
IVL Technology,
Coronary Clinical Data,
SWAV News,
Shockwave C2,
Coronary Conferences,
ChalkTalk Podcast,
Female vs. Male Outcomes
In a few weeks, we are headed to a city known for its sunshine and southern hospitality, Atlanta, Georgia, where SCAI 2022 is taking place this year. At the conference, leading calcium experts will share the 1-year results from the Randomized Disrupt PAD III Trial and 1-year sex specific outcomes with Coronary IVL.
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
Peripheral Conferences,
SWAV News,
Shockwave C2,
Coronary Conferences,
Shockwave S4,
Shockwave M5 & Shockwave M5+
Based on Shockwave’s recognition on Fast Company’s 2022 list of the World’s Most Innovative Companies in the medical device sector for “bringing good vibrations to heart procedures,” we sat down with Shockwave CEO Doug Godshall for a Q&A to discuss how innovation is fostered at SWAV and why continual innovation is imperative to the future success of the company.
You can also read more about the honor in the company’s press release, in which Doug is quoted saying, “Shockwave Medical was founded with innovation at our core…not only for pioneering revolutionary and proprietary IVL technology, but also for the ways that innovation permeates every aspect of our business. We are continually evolving and transforming how we do things as we seek to astound our customers with life changing products for the treatment of calcified cardiovascular disease.”
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
SWAV News,
ChalkTalk Podcast
In the latest ChalkTalk podcast, we’re going to listen in on a sponsored discussion that took place with TCTMD during TCT21 about new insights on the latest Coronary IVL data that was presented during the meeting with Drs. Ajay Kirtane, Alexandra Lansky, Matthew Price, and Ziad Ali. Hope you enjoy the conversation and for more information on the data, please visit LetsGetCracking.com.
Read More
Topics:
Coronary IVL,
IVL Technology,
SWAV News,
ChalkTalk Podcast,
Treating Different Ca++ Morphologies,
Female vs. Male Outcomes
In anticipation of TCT starting in early November, we had quick conversation with Shockwave Medical’s Chief Medical Officer, Dr. Keith Dawkins, about IVL’s presence at the meeting and the most interesting data coming out. Hope you enjoy his perspective!
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
SWAV News,
ChalkTalk Podcast
Explore the new world of Shockwave with Paul Higginbottom, Director of Sales in the UK and France, in ChalkTalk episode five. With over 10+ years in the medical device industry and a complex PCI background, Paul recounts the joys of his career journey but explains how the unique attributes of IVL and start-up environment are what compelled him to join Shockwave at the beginning of this year. He provides insights into Shockwave’s culture, shares challenges that he has faced already, and talks about going direct in the UK and France. Listen to catch Paul’s first interactions with physicians and their surprising feedback – enjoy!
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
SWAV News,
ChalkTalk Podcast
Follow the journey of Prof. James Spratt, a specialist in complex PCI and education, as he moves from early IVL adopter to expert in the technology. ChalkTalk episode four captures how Prof. Spratt, from St. George’s Hospital, University of London, first discovered Shockwave and why he now believes the technology is disruptive in the calcium space. Spratt describes how focusing on Optima education and practicing interventional cardiology helped get him to where he is today. Being an expert in the field, Spratt recognized the need for simplifying calcium education, which became the foundation that Shockwave and Optima's Calcium Masterclass was built upon. Hear more from Prof. James Spratt by tuning into the remaining Calcium Masterclasses!
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
SWAV News,
ChalkTalk Podcast